Research

Oncogenic viruses meet the environment

We combine molecular virology, cell biology and epidemiology to understand how DNA viruses and environmental carcinogens cooperate to drive human cancer.

HPV

HPV & epithelial carcinogenesis

High-risk human papillomavirus is etiologically linked to cervical, oropharyngeal and anogenital cancers. We investigate its role and mechanisms in these tumors and explore its possible contribution to extragenital cancers such as lung, breast and colorectal cancer.

CervixHead & neckRadioresistance
EBV

Epstein–Barr virus & environmental cofactors

We study how tobacco smoke and benzo[a]pyrene promote EBV reactivation and abortive lytic cycles, and how DNA damage favors viral latency in lung epithelial cells during carcinogenesis.

Lung cancerBenzo[a]pyreneViral latency
Synergy

Virus–carcinogen cooperation

Chemical carcinogens rarely act alone. We dissect the molecular cooperation between viral oncoproteins and agents such as aflatoxin (with hepatitis B virus in liver cancer) and benzo[a]pyrene, including effects on p53 and oxidative stress.

Aflatoxin · HBVp53Oxidative stress
Emerging

Emerging & co-occurring agents

Beyond classic oncoviruses, we examine MMTV-like viruses in breast cancer, Torque Teno virus in cervical disease, polyomaviruses, and the interaction between oncogenic viruses and genotoxic bacteria in colorectal cancer.

MMTV-likeTorque Teno virusVirus–microbiome
How we work

From patient samples to molecular mechanism

Our work spans the full translational arc, integrating clinical specimens with controlled cell models.

Molecular virology

Detection and genotyping of oncogenic viruses (PCR, qPCR), and functional analysis of viral genes in human samples and cell lines.

Cell & cancer biology

In vitro models of chronic carcinogen exposure to capture early preneoplastic reprogramming of epithelial cells.

Epidemiology

Cross-sectional studies estimating viral prevalence in Chilean patient cohorts across tumor types.

Funded research

Selected projects

2026 – 2030 Active

Rta-mediated reactivation of Epstein–Barr virus by benzo[a]pyrene: a mechanism for epithelial oncogenesis

Principal Investigator: F. Aguayo

2024 – 2026 Active

Viral infections related to cancer development: mechanisms and epidemiology

Principal Investigator: F. Aguayo

2022 – 2026 Active

EBV abortive lytic cycle promoted by tobacco smoke during epithelial carcinogenesis

Principal Investigator: F. Aguayo · Co-I: J. C. Tapia

2024 – 2025

Activation of the lytic cycle of Epstein–Barr virus in the presence of benzopyrene

Principal Investigator: F. Aguayo

2023 – 2025

EBV latency establishment promoted by DNA damage in lung cancer cells exposed to benzopyrene

Co-Principal Investigator: F. Aguayo

Curious about the science?

Browse our peer-reviewed work or reach out to discuss collaborations and student positions.

Read our publications